person

Milada M.

Country
Slovakia
Department
Outpatient care of clinical oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 92 partner sites.

Specializations

Breast Cancer Therapeutics

The investigator specializes in treating advanced breast cancer, with particular emphasis on hormone receptor-positive and HER2-negative disease. Their research interests encompass innovative therapeutic approaches for patients who have not previously received systemic treatment for advanced disease.

  • Hormone Receptor-Positive Breast Cancer
  • Advanced Disease Management
  • Treatment-Naïve Patients

Their therapeutic focus includes exploring combination treatment strategies for enhanced patient outcomes in breast cancer care.

Endocrine Therapy

The investigator concentrates on endocrine therapy approaches in breast cancer treatment, particularly examining novel therapeutic combinations. Their work involves evaluating various hormonal treatment strategies for patients with estrogen receptor-positive breast cancer.

  • Novel Endocrine Agents
  • Combination Therapy Approaches
  • Hormonal Treatment Strategies

Their expertise extends to investigating innovative therapeutic combinations that may improve treatment outcomes.

Targeted Therapies

The investigator focuses on developing and evaluating targeted therapeutic approaches for breast cancer treatment. Their research encompasses the study of CDK4/6 inhibition in combination with hormonal therapies.

  • Molecular Targeted Agents
  • Biomarker-Driven Treatment
  • Combination Treatment Strategies

Their work aims to advance personalized treatment approaches in breast cancer therapy.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.